Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation.

Transplantation - 1 Oct 2017

Fung James, Wong Tiffany, Chok Kenneth, Chan Albert, Sin Sui-Ling, Cheung Tan-To, Dai Wing-Chiu, Ng Kelvin, Ng Kevin, Man Kwan, Seto Wai-Kay, Lai Ching-Lung, Yuen Man-Fung, Lo Chung-Mau

Abstract excerpt

BACKGROUND: There is currently limited data regarding the use of oral antiviral therapy alone without hepatitis B immune globulin for chronic hepatitis B patients with preexisting lamivudine (LAM) resistance (LAM-R) undergoing liver transplantation. METHODS: This is a cohort study determining the effectiveness and long-term outcome in this group of patients. RESULTS: Fifty-seven consecutive chronic hepatitis B...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to End Stage Liver Disease

Share to Graft Survival

Share to Lamivudine

Share to Liver Transplantation

Share to Nucleosides

Share to Virus Activation

Source

Identifiers

PMID: 28731907
DOI: 10.1097/TP.0000000000001883

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation.PMID 28731907Read ↗

A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B.Semantic proximity Read ↗

Management of hepatitis B after renal transplantation: an update.Semantic proximity Read ↗

Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome.Semantic proximity Read ↗

Lamivudine as initial treatment for chronic hepatitis B in the United States.Semantic proximity Read ↗

Fulminant hepatic failure resulting from lamivudine-resistant hepatitis B virus in a renal transplant recipient: durable response after orthotopic liver transplantation on adefovir dipivoxil and hepatitis B immune globulin.Semantic proximity Read ↗

Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation.Semantic proximity Read ↗

Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation.Semantic proximity Read ↗

Hepatitis C treatment in patients on the liver transplant waiting list.Semantic proximity Read ↗

Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.Semantic proximity Read ↗

Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.Semantic proximity Read ↗

Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine.Semantic proximity Read ↗

Lamivudine therapy of chronic hepatitis B in three groups of patients: non transplanted patients, liver recipients, and kidney recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.